Impact of Midline Devices on Outcomes among Elderly PatientsAlessandro Felici*, Ferdinando Segala, Petra Luggin, Giuliano Parolin and Albert March
Department of Geriatrics, Bolzano's Central Public Hospital, Italy
- *Corresponding Author:
- Alessandro Felici
Department of Geriatrics
Bolzano's Central Public Hospital
Tel: +39 0471 908111
E-mail: [email protected]
Received date: May 30, 2016; Accepted date: June 21, 2016; Published date: June 24, 2016
Citation: Felici A, Segala F, Luggin P, Parolin G, March A (2016) Impact of Midline Devices on Outcomes among Elderly Patients. J Gerontol Geriatr Res 5: 316. doi:10.4172/2167-7182.1000316
Copyright: © 2016 Felici A, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
In recent years, we have witnessed significant developments in the intravenous drug administration sector. This is especially true in the case of patients whose therapy is expected to last longer than three days, and the infusion still meets the criteria for a peripheral line. In this clinical situation we have the availability of midline catheters, devices able to remain in place for the duration of therapy for mid-long term IV therapy, both for in and out of hospital therapies and both for continuous and discontinuous therapies.